Anagenics Ltd has released a press release.
Appendix 4C
Filed with ASX ·
On 6ix: 6ix.com/news/appendix-4c-58
6ix hasn’t read this filing yet.
Earlier from Anagenics
- Cellmid receives australian govt grant for midkine programme
- Cellmid Updates on CxBladder License
- Cellmid receives 831K R&D tax credit
- USA launch of evolis
- Cellmid: Appendix 3Y- Change of Director’s Interest Notice
Later from Anagenics
- Cellmids usa midkine patent for alopecia allowed
- Midkine alopecia patent european allowance
- Cellmid: Appendix 4D and Half Year Accounts
- Cellmid: to Refinance R&D Loan Facility
- Cellmids FGF5 inhibitor clinical study published
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics